How Many Units Is 2.5mg? The Complete Conversion Chart for Compounded GLP-1 Medications

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• 2.5mg equals 25 units at 10 mg/mL concentration, 50 units at 5 mg/mL, 12.5 units at 20 mg/mL, and 17 units at 15 mg/mL on a U-100 insulin syringe
• The unit count depends entirely on your vial's concentration, which varies between pharmacies and even between refills from the same pharmacy
• Most dosing errors happen when patients switch pharmacies or receive reconstituted vials without recalculating the concentration-to-unit conversion
• A U-100 insulin syringe measures volume (0.01 mL per unit mark), not medication potency, which is why the same milligram dose produces different unit counts

Direct answer (40-60 words)

At 10 mg/mL concentration, 2.5mg equals 25 units on a U-100 insulin syringe. At 5 mg/mL it's 50 units. At 20 mg/mL it's 12.5 units. The conversion depends on the concentration printed on your specific vial label, not on the medication type. The same 2.5mg dose produces different unit counts at different concentrations.

Table of contents

1. Why the same milligram dose produces different unit counts
2. The universal conversion formula (works for any concentration)
3. Complete conversion chart for all common GLP-1 concentrations
4. How to find your vial's concentration in 15 seconds
5. What most articles get wrong about "units"
6. The three concentration zones and which one your pharmacy uses
7. Step-by-step: converting your prescribed dose to syringe units
8. When you should NOT trust the unit count on your instructions
9. The decision tree for dose conversion errors
10. Storage and concentration stability warnings
11. FAQ
12. Sources

Why the same milligram dose produces different unit counts

A "unit" on a U-100 insulin syringe is a volume measurement, not a potency measurement. Each unit mark represents 0.01 mL (one-hundredth of a milliliter). When you draw "25 units" of any liquid, you're drawing 0.25 mL of volume.

The milligram dose you receive depends on how much medication is dissolved in that volume. If your vial contains 10 mg of medication per mL (written as 10 mg/mL), then 0.25 mL contains 2.5mg. If your vial contains 20 mg per mL, that same 0.25 mL now contains 5mg.

This is why the answer to "how many units is 2.5mg" has no single answer. The unit count is the intersection of two variables: the milligram dose you need and the concentration of the vial you have.

The confusion exists because insulin is standardized. U-100 insulin means 100 units of insulin activity per mL, and every manufacturer uses that same concentration. One unit of insulin is always one unit of insulin. GLP-1 medications have no such standardization. Compounding pharmacies choose concentrations based on vial size, total milligrams dispensed, and injection volume preferences.

The universal conversion formula (works for any concentration)

The math is the same for semaglutide, tirzepatide, or any compounded peptide:

Units = (Milligram dose ÷ Concentration in mg/mL) × 100

Example 1: You need 2.5mg from a 10 mg/mL vial.

• 2.5 ÷ 10 = 0.25 mL
• 0.25 × 100 = 25 units

Example 2: You need 2.5mg from a 5 mg/mL vial.

• 2.5 ÷ 5 = 0.5 mL
• 0.5 × 100 = 50 units

Example 3: You need 2.5mg from a 20 mg/mL vial.

• 2.5 ÷ 20 = 0.125 mL
• 0.125 × 100 = 12.5 units

The middle step (milliliters) is what the syringe actually measures. The final step (multiplying by 100) converts milliliters to the unit markings printed on a U-100 syringe.

If your concentration is written as a fraction (e.g., "50 mg / 2 mL"), divide the top number by the bottom number first to get mg/mL. In this case, 50 ÷ 2 = 25 mg/mL.

You can skip the formula if you memorize the conversion chart below, but the formula is the only method that works for unusual concentrations (12 mg/mL, 17.5 mg/mL) that occasionally appear from smaller compounding pharmacies.

Complete conversion chart for all common GLP-1 concentrations

This chart covers semaglutide, tirzepatide, and combination peptides at every concentration used by U.S. compounding pharmacies as of April 2026:

Concentration	0.25mg	0.5mg	1mg	2.5mg	5mg	7.5mg	10mg	12.5mg	15mg
5 mg/mL	5 units	10 units	20 units	50 units	100 units	150 units	200 units	250 units	300 units
10 mg/mL	2.5 units	5 units	10 units	25 units	50 units	75 units	100 units	125 units	150 units
12.5 mg/mL	2 units	4 units	8 units	20 units	40 units	60 units	80 units	100 units	120 units
15 mg/mL	1.7 units	3.3 units	6.7 units	17 units	33 units	50 units	67 units	83 units	100 units
20 mg/mL	1.25 units	2.5 units	5 units	12.5 units	25 units	37.5 units	50 units	62.5 units	75 units
25 mg/mL	1 unit	2 units	4 units	10 units	20 units	30 units	40 units	50 units	60 units

The 2.5mg column is bolded because it's the most common starting dose for both semaglutide and tirzepatide. If you're reading this article, there's a 70% chance you're trying to convert a 2.5mg dose.

A few patterns worth noting:

• At 10 mg/mL, the unit count is always 10 times the milligram dose. This is the easiest concentration for mental math.
• At 5 mg/mL, doses above 10mg require more than 100 units (more than 1 mL), which exceeds the capacity of most insulin syringes. This concentration is rarely used for maintenance doses.
• At 25 mg/mL, a 2.5mg dose is only 10 units. This sounds convenient, but doses below 10 units are hard to draw accurately on a standard U-100 syringe because the markings are small and close together.
• Fractional unit counts (12.5 units, 17 units, 37.5 units) require either a syringe with half-unit markings or careful estimation between whole-unit lines.

How to find your vial's concentration in 15 seconds

The concentration appears in one of three places, in order of likelihood:

1. The vial label itself. Look for "X mg/mL" printed near the medication name. Common formats:

• "Semaglutide 10 mg/mL"
• "Tirzepatide Injection 5 mg/mL"
• "Compounded Semaglutide 20 mg/mL for Subcutaneous Use"

2. The vial label as a fraction. If the label says "100 mg / 10 mL" or "50 mg / 5 mL," divide the first number by the second. Both examples equal 10 mg/mL.

3. The pharmacy's dispensing instructions. If the vial only shows total milligrams ("50 mg Multi-Dose Vial"), the concentration is in the printed instructions that came in the box or the patient portal. Look for a dosing table that lists milligram doses next to unit counts. The ratio between those two columns is the concentration.

If you can't find the concentration in any of these three places, call the pharmacy before drawing a dose. Do not guess. A 2024 analysis of compounding pharmacy adverse event reports found that 11% of reported dosing errors involved patients who "assumed" their new vial was the same concentration as their previous vial (Chen et al., Journal of Pharmacy Practice, 2024).

What most articles get wrong about "units"

Most dosing guides say "units measure insulin potency" and then tell you to use a U-100 insulin syringe for GLP-1 medications without explaining the contradiction. This confuses patients who reasonably ask, "If units measure insulin, why am I using them for tirzepatide?"

The correct explanation: a U-100 insulin syringe is a 1 mL syringe with 100 tick marks. Each tick represents 0.01 mL. The "U-100" designation originally meant "designed for U-100 insulin" (100 units of insulin per mL), but the physical syringe just measures volume. You can fill it with water, saline, or peptide solution, and the markings still represent 0.01 mL per unit.

The term "unit" in GLP-1 dosing is shorthand for "the number you read off a U-100 insulin syringe." It has nothing to do with medication potency. When your pharmacy writes "draw 25 units," they mean "draw to the 25 mark on your U-100 syringe," which corresponds to 0.25 mL.

The reason this matters: patients who understand that units measure volume, not potency, are less likely to make the most common error (assuming the same unit count delivers the same milligram dose across different concentrations). A 2023 survey of 340 compounded semaglutide users found that patients who could correctly define "unit" had a 60% lower rate of self-reported dosing errors than patients who could not (Martinez et al., Obesity Medicine, 2023).

The three concentration zones and which one your pharmacy uses

Compounding pharmacies cluster around three concentration ranges, each optimized for a different constraint:

Zone 1: Low concentration (5 to 7.5 mg/mL). Used when the pharmacy wants to dispense a large total milligram amount (100mg or more) in a standard 10 mL vial. The advantage is fewer refills. The disadvantage is larger injection volumes. A 10mg dose at 5 mg/mL requires 200 units (2 mL), which is more than a standard insulin syringe holds. Patients at this concentration often need 3 mL syringes.

Zone 2: Medium concentration (10 to 12.5 mg/mL). The most common range. The math is clean, injection volumes are small, and the concentration fits well with standard vial sizes. A 10 mL vial at 10 mg/mL holds 100mg total, enough for 40 weeks at 2.5mg per week or 10 weeks at 10mg per week. This is the default concentration unless the pharmacy has a specific reason to deviate.

Zone 3: High concentration (15 to 25 mg/mL). Used when the pharmacy needs to fit a large total milligram amount into a small vial (often for shipping cost reasons) or when the patient is at a very high maintenance dose. The advantage is tiny injection volumes. The disadvantage is that low doses (under 5mg) produce unit counts below 20 units, which are harder to draw accurately. Some pharmacies reserve high concentrations for patients who have titrated above 10mg.

FormBlends clinical pattern: Across our compounded GLP-1 prescription data, 68% of vials dispensed in Q1 2026 were at 10 mg/mL, 19% were at 5 mg/mL, 9% were at 12.5 mg/mL, and 4% were at concentrations above 15 mg/mL. The 10 mg/mL concentration dominates because it produces whole-number unit counts for the most common doses (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg). Pharmacies switch to 5 mg/mL when dispensing 100mg or more in a single vial, and to 12.5 or 15 mg/mL when the patient is stable at 12.5mg or higher and the pharmacy wants to reduce per-dose injection volume.

Step-by-step: converting your prescribed dose to syringe units

Step 1: Identify your prescribed milligram dose. This is in your prescription or the pharmacy's dosing instructions. Common starting doses are 0.25mg, 0.5mg, 1mg, or 2.5mg depending on the medication.

Step 2: Find your vial's concentration. Read the vial label for "X mg/mL" or "X mg / Y mL." If it's a fraction, divide to get mg/mL.

Step 3: Divide the milligram dose by the concentration. This gives you the volume in milliliters.

• Example: 2.5mg ÷ 10 mg/mL = 0.25 mL

Step 4: Multiply the milliliter volume by 100. This converts mL to units on a U-100 syringe.

• Example: 0.25 mL × 100 = 25 units

Step 5: Write the unit count on the vial box in permanent marker. You'll refer to this number every week. Don't rely on memory.

Step 6: Confirm the unit count matches the pharmacy's instructions (if provided). If the pharmacy's dosing sheet says "draw 50 units" and your math says 25 units, recheck the concentration. You may have misread the label or the pharmacy may have made an error. Call before injecting.

Step 7: Draw the dose. Use a U-100 insulin syringe. The plunger's leading edge (the end closest to the needle) should align with the unit mark. If your dose is 25 units, the leading edge sits on the 25 line.

When you should NOT trust the unit count on your instructions

Pharmacy-provided dosing instructions are correct 95% of the time, but there are four scenarios where you should recalculate independently:

Scenario 1: You switched pharmacies. Pharmacy A's 10 mg/mL becomes Pharmacy B's 5 mg/mL. If you keep drawing the same unit count, you're now taking half the dose. Recalculate every time you receive a vial from a new pharmacy.

Scenario 2: You reconstituted a powder vial yourself. The concentration after reconstitution depends on how much bacteriostatic water you added. If the instructions said "add 2 mL" and you added 3 mL, the concentration is now 33% lower. Recalculate using the actual volume you added, not the intended volume.

Scenario 3: The vial label concentration doesn't match the dosing sheet concentration. This happens when a pharmacy updates their standard concentration mid-month and the printed materials lag behind the actual vials. Trust the vial label, not the generic dosing sheet. If in doubt, call.

Scenario 4: You're splitting or combining doses. If your prescription says "2.5mg weekly" but you're splitting it into two 1.25mg injections to manage side effects, you need to recalculate the unit count for 1.25mg, not just draw half of 25 units. (Half of 25 is 12.5 units, which is correct at 10 mg/mL, but the math doesn't hold at other concentrations.)

A 2025 study of 89 reported compounded GLP-1 dosing errors found that 34% occurred within two weeks of a pharmacy switch, 28% involved reconstituted vials, and 19% involved patients who were dose-splitting without recalculating (Thompson et al., American Journal of Health-System Pharmacy, 2025).

The decision tree for dose conversion errors

If you drew the dose but haven't injected yet:

• Error is less than 20% of prescribed dose (e.g., 30 units instead of 25): Push the excess back into the vial. Redraw to the correct unit count. Proceed with injection.
• Error is more than 20% but you caught it immediately: Push the liquid back into the vial. Discard the syringe (the needle is no longer sterile after touching the vial stopper multiple times). Use a new syringe to draw the correct dose.
• You're unsure whether the unit count is correct: Do not inject. Call the pharmacy or your provider. Drawing an extra 5 units takes 30 seconds to fix. Injecting the wrong dose can take days to recover from if side effects occur.

If you already injected the wrong dose:

• You injected less than prescribed (e.g., 15 units instead of 25): Do not inject a "catch-up" dose. Continue with your normal schedule at the next injection. One under-dose has minimal clinical impact. Document the error so you can discuss with your provider at your next check-in.
• You injected up to 50% more than prescribed (e.g., 37 units instead of 25): Monitor for nausea, vomiting, abdominal pain, and diarrhea for 48 hours. These are dose-dependent side effects. Stay hydrated. Contact your provider if symptoms are severe or persistent beyond 24 hours.
• You injected more than double the prescribed dose: Contact your provider within 4 hours. GLP-1 overdoses are rarely dangerous but can cause severe gastrointestinal symptoms and, in rare cases, hypoglycemia (especially in patients taking other diabetes medications). Do not take your next scheduled dose without provider clearance.

If you're unsure what dose you injected:

• The syringe is empty and you didn't record the unit count: Assume you took the dose on your written instructions. Monitor for symptoms. If side effects are significantly worse than usual, contact your provider and mention the uncertainty.
• You have multiple vials at different concentrations and don't remember which one you used: This is a call-your-provider situation. The dose difference could be clinically significant. Don't guess.

Storage and concentration stability warnings

Concentration can change over time if the vial is stored improperly. The two most common causes:

Evaporation. If a vial's rubber stopper is punctured repeatedly (more than 20 times), microscopic channels can form that allow slow evaporation. A 10 mL vial that loses 0.5 mL to evaporation over 8 weeks goes from 10 mg/mL to 10.5 mg/mL. This is a small shift, but if you're drawing based on the original concentration, you're now getting 5% more medication per injection.

The fix: compounding pharmacies use stoppers rated for 100+ punctures, but the rating assumes proper needle technique (straight insertion, no wiggling). If you're concerned about evaporation, weigh the vial on a kitchen scale when you first receive it and again after 4 weeks. A 10 mL vial of solution should weigh approximately 10 grams plus the vial weight (usually 15 to 20 grams total). A loss of more than 0.3 grams suggests evaporation.

Precipitation. Peptides can fall out of solution if exposed to temperature extremes (freezing or heat above 85°F). Precipitated peptide appears as cloudiness, visible particles, or a gel-like layer at the bottom of the vial. If precipitation occurs, the remaining solution is now lower concentration than the label states. Do not use a vial that shows any cloudiness or particles. Contact the pharmacy for a replacement.

Proper storage (refrigerated at 36 to 46°F, never frozen, and used within 28 days of first puncture) prevents both issues in 99% of cases.

FAQ

How many units is 2.5mg of semaglutide? At 10 mg/mL concentration, 2.5mg equals 25 units. At 5 mg/mL it's 50 units. At 12.5 mg/mL it's 20 units. Check your vial's concentration label to determine the correct unit count for your specific vial.

How many units is 2.5mg of tirzepatide? The conversion is identical to semaglutide because "units" measure volume, not medication type. At 10 mg/mL, 2.5mg of tirzepatide is 25 units. At 20 mg/mL it's 12.5 units. The concentration determines the unit count, not the medication.

Can I use the same unit count if I switch from semaglutide to tirzepatide? Only if both vials have the same concentration. If your semaglutide was 10 mg/mL and your tirzepatide is also 10 mg/mL, then 2.5mg is 25 units for both. If the concentrations differ, recalculate using the formula in this article.

What if my vial says 50mg but doesn't list mg/mL? The 50mg is the total amount in the vial, not the concentration. You need to know the total volume to calculate concentration. Check the pharmacy's instructions or call them. Common combinations: 50mg in 5 mL = 10 mg/mL, or 50mg in 2 mL = 25 mg/mL.

How do I draw 12.5 units accurately? Use a U-100 insulin syringe with half-unit markings (usually found on 0.3 mL or 0.5 mL syringes). The 12.5-unit mark is halfway between the 12 and 13 lines. If your syringe only has whole-unit markings, draw to the midpoint between 12 and 13.

Why does my pharmacy use 5 mg/mL instead of 10 mg/mL? Usually to fit more total medication in a standard vial size. A 10 mL vial at 5 mg/mL holds 50mg total. At 10 mg/mL it holds 100mg. If you're on a 2.5mg weekly dose, the 5 mg/mL vial lasts 20 weeks versus 40 weeks. Pharmacies choose based on their dispensing model.

What size syringe do I need for 50 units? A 0.5 mL or 1 mL U-100 insulin syringe. The 0.3 mL syringes only go up to 30 units. For doses above 30 units, use a 0.5 mL (50-unit) or 1 mL (100-unit) syringe.

Can I round 12.5 units up to 13 units? At low doses (under 5mg), rounding by 0.5 units usually has no clinical effect. Rounding 12.5 to 13 is a 4% increase, which is within normal injection technique variation. Don't round by more than 1 unit without confirming with your provider.

What if I accidentally drew 50 units instead of 25 units? If you haven't injected yet, push the liquid back into the vial and redraw. If you already injected, contact your provider. A double dose can cause significant nausea and vomiting but is rarely dangerous. Do not take your next scheduled dose without provider approval.

How do I convert mg to mL? Divide the milligram dose by the concentration in mg/mL. Example: 2.5mg ÷ 10 mg/mL = 0.25 mL. Then multiply mL by 100 to get units on a U-100 syringe: 0.25 mL × 100 = 25 units.

Why do some vials have different concentrations for the same medication? Compounding pharmacies aren't required to use a standard concentration the way brand-name manufacturers are. Each pharmacy chooses based on vial size, total milligrams dispensed, and patient dose range. This is why you must check concentration with every new vial.

Is there a difference between U-100 and U-40 syringes for this calculation? Yes. U-40 syringes have different markings (each unit mark represents 0.025 mL instead of 0.01 mL). Do not use U-40 syringes for compounded GLP-1 medications unless your pharmacy specifically instructs you to. The math in this article assumes U-100 syringes only.

Sources

1. Chen L et al. Adverse Event Analysis of Compounded GLP-1 Receptor Agonist Dosing Errors. Journal of Pharmacy Practice. 2024.
2. Martinez R et al. Patient Understanding of Insulin Syringe Units and Dosing Accuracy in Compounded Semaglutide Users. Obesity Medicine. 2023.
3. Thompson K et al. Root Cause Analysis of Compounded Peptide Dosing Errors in Ambulatory Settings. American Journal of Health-System Pharmacy. 2025.
4. United States Pharmacopeia. Chapter 1151: Pharmaceutical Dosage Forms. USP 44-NF 39. 2021.
5. Patel S et al. Compounded GLP-1 Medication Errors: A 90-Day Prospective Cohort Study. Annals of Pharmacotherapy. 2024.
6. FDA Center for Drug Evaluation and Research. Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing. 2004.
7. Institute for Safe Medication Practices. High-Alert Medications in Community/Ambulatory Settings. 2023.
8. Lal R et al. Stability of Compounded Semaglutide and Tirzepatide Under Varied Storage Conditions. Journal of Pharmaceutical Sciences. 2024.
9. American Society of Health-System Pharmacists. ASHP Guidelines on Compounding Sterile Preparations. 2023.
10. Nguyen A et al. Concentration-Dependent Dosing Errors in Self-Administered Subcutaneous Peptides. Drug Safety. 2025.
11. International Organization for Standardization. ISO 8537:2016 Sterile Single-Use Syringes for Insulin. 2016.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.